# OnCo record hangzhou-hanx-biopharmaceuticals (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/hangzhou-hanx-biopharmaceuticals/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "hangzhou-hanx-biopharmaceuticals" ;
  schema:name "Hangzhou Hanx Biopharmaceuticals"@en ;
  schema:alternateName "Hangzhou Hanx Biopharmaceuticals, Ltd."@en ;
  schema:description "Hangzhou Hanx Biopharmaceuticals is a China-based biotechnology company running 2 late-stage cancer trials of HX009 in glioma & glioblastoma, biliary tract cancer and melanoma."@en ;
  schema:url <https://onco.cc/companies/hangzhou-hanx-biopharmaceuticals/>, <https://www.hanxbio.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.hanxbio.com>, <https://clinicaltrials.gov/search?lead=Hangzhou%20Hanx%20Biopharmaceuticals%2C%20Ltd.> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/>, <https://onco.cc/cancers/cholangiocarcinoma/>, <https://onco.cc/cancers/melanoma/> ;
  onco:trials <https://onco.cc/trials/nct06649708/>, <https://onco.cc/trials/nct06708663/>, <https://onco.cc/trials/nct06703255/> .
